Who
Michael R. Friedman
Director
Company insider
Files Form 4 as: Director, Galera Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 30 Dec 2024
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code D | —41,631 | filing |
| 3 Aug 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —480 | filing |
| 3 Aug 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —480 | filing |
| 3 Aug 2026filed 5 Aug 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code D | —41,631 | filing |
| 15 May 2026filed 5 Aug 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code C | —2,989,399 | filing |
| 15 May 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —2,989.399 at $0.00 | filing |
| 15 May 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —2,989.4 at $0.00 | filing |
| 15 May 2026filed 5 Aug 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code C | —2,989,399 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code C | —5,336,870 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —5,336.87 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —5,336.87 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code C | —5,336,870 | filing |
| 24 Feb 2025filed 26 Feb 2025 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —96,000 at $0.00 | filing |
| 30 Dec 2024filed 2 Jan 2025 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,326.27 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.